查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1972589

獸醫外科市場：按動物類型、手術類型、技術和最終用戶分類，全球預測，2026-2032年

Veterinary Surgical Procedures Market by Animal Type, Procedure Type, Technique, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，獸醫外科市場價值將達到 445.5 億美元，到 2026 年將成長至 477.8 億美元，到 2032 年將達到 731.4 億美元，複合年成長率為 7.33%。

主要市場統計數據
基準年 2025 445.5億美元
預計年份：2026年 477.8億美元
預測年份 2032 731.4億美元
複合年成長率 (%) 7.33%

權威概述了現代獸醫外科生態系統，其發展受到日益複雜的臨床情況、技術進步和多樣化的醫療保健服務環境的驅動。

獸醫外科領域已發展成為一個融合了先進臨床技術、科技創新和不斷演進的醫療服務模式的複雜領域。本文概述了塑造現代獸醫實踐的核心要素：病例類型日益多樣化，涵蓋伴侶動物、馬匹和家禽/牲畜；手術類型日益複雜，涉及牙科、神經科、眼科、整形外科和軟組織介入；以及微創手術、開放式手術和機器人輔助手術等多種技術的逐步應用。這些趨勢共同作用，正在改變臨床醫生、醫療機構和供應方相關人員對投資和營運流程的優先排序。

重大變革正在重新定義獸醫外科實踐，影響臨床工作流程、籌資策略和組織能力。

近年來，獸醫外科領域經歷了變革性的變化，重塑了臨床工作流程、資金配置和競爭格局。影像學和手術全期監測技術的進步提高了診斷準確性，並擴大了可進行的複雜手術範圍。同時，微創和關節鏡技術的廣泛應用縮短了恢復時間，改變了飼主對術後效果的預期。此外，機器人技術和先進電外科平台的整合應用，使得手術操作更具可重複性，尤其是在整形外科和軟組織外科領域，這也促使訓練需求和籌資策略改變。

評估美國2025年關稅變化將如何重塑供應鏈、採購決策以及獲得先進外科技術的途徑。

2025年的政策環境將出現關稅變化，將對外科器械和耗材的採購、庫存管理和策略採購產生影響。進口外科器械、機器人組件和特種植入的關稅調整可能導致依賴全球供應商的醫療專業人員和機構的前置作業時間延長和到岸成本增加。這些變化迫使各機構重新評估供應商合約、保固條款和長期維護協議，從而顯著影響資本支出週期和複雜手術中的服務可用性。

我們透過可操作的細分分析來支持臨床和商業性策略的製定，該分析將動物物種、治療類別、外科手術程序和最終用戶概況聯繫起來。

市場區隔揭示了不同的需求促進因素和營運要求，這些因素應指南產品開發和市場進入策略。不同動物物種的市場動態存在差異：伴侶動物、馬匹和家畜/家禽。伴侶動物類別進一步細分為貓和狗，而家畜/家禽類別則區分為牲畜和家禽。每個動物群體都有其獨特的解剖結構、麻醉通訊協定以及植入和器械偏好，都會影響設備設計和臨床醫生培訓的重點。

區域比較分析突顯了醫療保健結構、法規環境和需求訊號的差異如何影響外科治療方法。

區域差異影響著服務提供、監管和合作夥伴選擇的策略重點。美洲地區擁有成熟的、功能完善的轉診網路和完善的獸醫醫院體系，推動了對先進診斷影像、整形外科和微創手術工具的需求，同時也促進了合作臨床研究和專科培訓計畫的發展。相較之下，歐洲、中東和非洲地區則呈現顯著的差異。一些歐洲市場強調標準化的臨床通訊協定和更嚴格的監管，中東地區則有選擇地投資於三級轉診能力，而非洲部分地區則致力於擴大外科手術的覆蓋範圍和發展人力資源。

深入洞察產業競爭格局，了解設備、服務和培訓的整合解決方案如何提升臨床療效和營運韌性。

整個價值鏈上的關鍵參與者正朝著整合設備、服務、培訓和數位化支援的一體化解決方案方向發展。手術器械製造商擴大將圍手術全期培訓計畫和遠端維護合約打包銷售，以減輕臨床醫生的工作量。同樣，開發成像、遙測和機器人系統的技術提供者也優先考慮互通性和以用戶為中心的設計，以縮短混合診療環境下的學習曲線。醫療設備開發商與獸醫學院附屬醫院之間的策略合作日益普遍，這有助於加速臨床檢驗，並促進以案例為基礎的新技術培訓。

為領導者提供切實可行的優先建議，以加強供應鏈韌性、加速臨床部署並建立滿足供應商需求的商業模式。

產業領導者應優先採取策略行動，平衡短期韌性和長期能力建構。首先，實現供應商網路多元化，並協商靈活的服務契約，以減輕關稅引發的成本轉移和供應中斷對營運的影響。其次，投資於結合模擬學習和指導的臨床醫生培訓項目，以加速微創和機器人技術的安全應用，減少手術操作差異和併發症。第三，設計符合每位終端用戶需求的客製化產品和服務組合，以降低應用門檻，確保轉診機構、診所和醫院能夠獲得適當的資金籌措和共享使用協議。

為了檢驗臨床和操作方面的見解，我們採用了一種穩健的混合研究途徑，結合了從業人員訪談、通訊協定分析和三角驗證。

本分析所依據的研究嚴格驗證並整合了第一手和第二手證據，以確保其可靠性和相關性。第一手資料包括對執業外科醫生、醫院管理人員、供應鏈經理以及轉診中心、獸醫醫院和診所的高級臨床醫生進行的詳細訪談，並輔以結構化檢驗，以了解營運重點和推廣障礙。第二手研究整合了同行評審的臨床文獻、監管指南、醫療設備註冊資料和技術規範，以整理技術發展路徑和安全考量。

這份簡明扼要、全面且全面的分析報告，重點闡述了臨床創新、營運策略和區域差異的交匯點，提出了決定未來獸醫外科領域領導地位的關鍵因素。

總之，獸醫外科領域正處於技術能力、臨床專長和商業策略交會的十字路口，共同塑造未來的醫療保健標準。微創技術、先進影像技術和新興機器人應用的融合，正在拓展可治療疾病的範圍；而按動物種類、手術類型、技術類型和最終用戶進行細分，則為有針對性的創新和應用提供了清晰的路徑。考慮到基礎設施、監管和投資意願的區域差異，需要製定既能反映當地實際情況又不放棄全球最佳實踐的細緻策略。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：獸用外科市場：依動物類型分類

  • 伴侶動物
    • 貓
    • 狗
  • 馬匹
  • 畜禽
    • 家畜
    • 家禽

第9章：獸醫外科市場：依手術類型分類

  • 牙科
  • 神經外科
  • 眼科
  • 整形外科
  • 軟組織

第10章：獸用外科市場：依技術分類

  • 微創手術
    • 關節鏡手術
    • 腹腔鏡
  • 開放性手術
  • 機器人

第11章 獸醫外科手術市場：依最終使用者分類

  • 轉診中心
  • 動物診所
  • 動物醫院

第12章 獸醫外科手術市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 獸醫外科手術市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 獸醫外科手術市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國：獸醫外科市場

第16章 中國：獸用外科器械市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Covetrus, Inc.
  • Henry Schein, Inc.
  • Heska Corporation
  • Jorgen Kruuse A/S
  • Medtronic plc
  • Midmark Corp.
  • Patterson Companies, Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Vetoquinol SA
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-2B5802CFEDCC

The Veterinary Surgical Procedures Market was valued at USD 44.55 billion in 2025 and is projected to grow to USD 47.78 billion in 2026, with a CAGR of 7.33%, reaching USD 73.14 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 44.55 billion
Estimated Year [2026] USD 47.78 billion
Forecast Year [2032] USD 73.14 billion
CAGR (%) 7.33%

An authoritative orientation to the modern veterinary surgical ecosystem driven by clinical complexity, technology adoption and diverse care delivery settings

The landscape of veterinary surgical procedures has matured into a complex intersection of clinical sophistication, technological innovation, and evolving care delivery models. This introduction frames the core elements shaping contemporary practice: the diversification of case mix across companion animals, equine patients and livestock poultry; the rising complexity of procedure types spanning dental, neurological, ophthalmic, orthopedic and soft tissue interventions; and the progressive adoption of varied techniques such as minimally invasive approaches, open surgery and robotic assistance. Together these dynamics are reshaping how clinicians, institutions and supply-side stakeholders prioritize investments and operational processes.

As we move from descriptive observation to strategic perspective, it is essential to acknowledge the heterogeneous end-user landscape that includes referral centers, traditional veterinary clinics and hospital settings. Each of these settings imposes different expectations for equipment, staffing, perioperative protocols and outcome metrics. Moreover, shifting owner expectations for companion animals, regulatory attention to food-animal welfare, and expanding specialty training for veterinarians are reinforcing a trajectory toward higher-acuity, technology-enabled care. This introduction establishes the baseline for the deeper analyses that follow, spotlighting practical levers that influence adoption, reimbursement-like mechanisms in different jurisdictions, and the operational choices that translate clinical capability into sustainable service lines.

Key transformative shifts redefining veterinary surgical practice that impact clinical workflows, procurement strategies and institutional capabilities

Over recent years the veterinary surgical field has experienced transformative shifts that recalibrate clinical workflows, capital allocation and competitive positioning. Advances in imaging and perioperative monitoring have raised diagnostic precision and broadened candidacy for complex procedures, while the proliferation of minimally invasive and arthroscopic techniques has shortened recovery times and shifted owner expectations for postoperative outcomes. Concurrently, integration of robotics and enhanced electrosurgical platforms is enabling more reproducible interventions, especially in orthopedic and soft tissue specialties, which alters training requirements and procurement strategies.

In parallel, changes in practice organization are notable: referral centers are consolidating high-acuity caseloads while general clinics increasingly partner with specialty providers or develop hybrid service models. This redistribution of case loads amplifies demand for specialized consumables and device interoperability. Supply chain resilience has become a strategic priority, prompting stakeholders to seek diversified sourcing and local service agreements. Finally, regulatory and welfare imperatives are driving greater standardization of surgical protocols and outcome reporting. Collectively, these shifts are not isolated; they create cascading effects across staffing, capital planning and vendor relationships, and require cross-functional orchestration to translate clinical innovation into measurable improvements in care quality and operational efficiency.

Assessment of how tariff shifts in the United States are reshaping supply chains, procurement decisions and access to advanced surgical technologies in 2025

The policy environment in 2025 has introduced tariff dynamics that reverberate across procurement, inventory management and strategic sourcing for surgical equipment and consumables. Tariff adjustments on imported surgical instruments, robotics components and specialized implants can extend lead times and increase landed costs for practitioners and institutions that depend on global suppliers. These changes compel organizations to reassess supplier contracts, warranty provisions, and long-term maintenance agreements, with material effects on capital expenditure cycles and service availability for high-complexity procedures.

Beyond immediate cost implications, tariffs influence supplier behavior: manufacturers may accelerate localization of manufacturing, restructure distribution networks, or shift product portfolios toward higher-margin items. For end users such as referral centers, veterinary clinics and hospitals, there is a parallel need to evaluate inventory buffers and to negotiate service-level agreements that account for cross-border logistics risk. In addition, research and innovation pathways can be affected if components for next-generation devices face import constraints, slowing clinical validation or commercialization timelines. Ultimately, the cumulative impact of tariff policy requires coordinated responses from procurement, clinical leadership and industry partners to preserve continuity of care and maintain access to advanced surgical modalities.

Actionable segmentation insights linking animal types, procedure categories, surgical techniques and end-user profiles to inform targeted clinical and commercial strategies

Segmentation reveals differentiated demand drivers and operational requirements that should guide product development and go-to-market strategies. Based on Animal Type, market dynamics diverge across Companion Animal, Equine Animal, and Livestock Poultry; the Companion Animal category further differentiates into Cats and Dogs, and the Livestock Poultry category distinguishes between Livestock and Poultry. Each animal grouping presents unique anatomical considerations, anesthesia protocols and implant or instrument preferences that influence device design and clinician training priorities.

Based on Procedure Type, the spectrum from dental through neurological, ophthalmic, orthopedic and soft tissue interventions maps to distinct capital intensity and consumable profiles, creating varied adoption pathways. Based on Technique, the field encompasses Minimally Invasive, Open, and Robotic approaches, with Minimally Invasive further studied across Arthroscopic and Laparoscopic modalities; this technical segmentation highlights a trajectory toward less invasive care that demands investment in specialized optics, insufflation and instrumentation. Finally, based on End User, differentiation among Referral Centers, Veterinary Clinics, and Veterinary Hospitals underscores differences in case complexity, procurement sophistication and staff specialization. Synthesizing these segment layers enables targeted clinical education, tailored product bundles and differentiated service models that align with the clinical and commercial needs of each segment.

Comparative regional analysis highlighting how divergent healthcare structures, regulatory environments and demand signals shape surgical capability adoption

Regional variation shapes strategic priorities across service delivery, regulation and partner selection. The Americas tend to exhibit a mature mix of high-specification referral networks and well-established veterinary hospital systems that drive demand for advanced imaging, orthopedic and minimally invasive toolsets, while also fostering collaborative clinical research and specialty training programs. In contrast, Europe, Middle East & Africa displays pronounced heterogeneity: several European markets emphasize standardized clinical protocols and higher regulatory scrutiny, the Middle East is investing selectively in tertiary referral capacity, and parts of Africa are focusing on expanding baseline surgical access and workforce development.

Meanwhile, the Asia-Pacific region presents a dual profile of rapidly expanding companion animal care in urban centers and a continuing need for scalable solutions in emerging markets. Across all regions, localization of supply chains, region-specific training initiatives, and tailored financing solutions play critical roles in adoption. Transitioning between regional profiles requires adaptive commercialization tactics that respect regulatory nuance, local epidemiology, and varying owner expectations, while leveraging partnerships with academic institutions and regional distributors to accelerate capability building and technology diffusion.

Industry-level intelligence on competitive convergence toward integrated device, service and training solutions that enhance clinical outcomes and operational resilience

Key players across the value chain are converging toward integrated offerings that pair devices with service, training and digital support. Manufacturers of surgical instrumentation are increasingly bundling perioperative training programs and remote maintenance agreements to reduce operational friction for clinicians. Similarly, technology providers that develop imaging, telemetry and robotic systems are prioritizing interoperability and user-centric design to lower the learning curve in mixed-practice environments. Strategic partnerships between device innovators and veterinary teaching hospitals are becoming common, accelerating clinical validation and facilitating case-based training for new techniques.

On the provider side, referral centers are consolidating specialty expertise and investing in multidisciplinary teams that can manage complex neurological, orthopedic and ophthalmic cases. Veterinary hospitals and clinics that aim to expand service scope are forming co-investment arrangements or equipment-sharing consortia to access capital-intensive modalities. Across these movements, the competitive frontier is defined by the ability to deliver demonstrable clinical outcomes, scalable training pathways, and robust post-sale support rather than by single-product superiority. This evolving ecosystem rewards entities that can align clinical efficacy with pragmatic operational support and continuous education.

Practical and prioritized recommendations for leaders to strengthen supply resilience, accelerate clinical adoption and align commercial models with provider needs

Industry leaders should prioritize strategic actions that balance near-term resilience with long-term capability building. First, diversify supplier networks and negotiate flexible service contracts to mitigate the operational impacts of tariff-driven cost shifts and supply disruptions. Second, invest in clinician training programs that accelerate safe adoption of minimally invasive and robotic techniques, pairing simulation-based learning with proctoring to reduce procedural variability and complications. Third, design product and service bundles that align with the needs of distinct end users, ensuring that referral centers, clinics and hospitals can access appropriate financing or shared-use arrangements to lower adoption barriers.

Additionally, pursue data-driven outcomes measurement to demonstrate value for owners and regulators, and leverage these metrics in commercial discussions and payer dialogs. Expand partnerships with academic centers and regional training hubs to build the talent pipeline and validate new device applications. Finally, adopt modular product strategies that allow incremental upgrades rather than wholesale replacement, thereby preserving capital flexibility for providers and creating predictable upgrade revenue streams for suppliers. These combined measures will enhance clinical capacity, protect margin, and position organizations to capture growth as procedural complexity continues to rise.

A robust mixed-methods research approach combining practitioner interviews, protocol analysis and triangulation to validate clinical and operational findings

The research underpinning this analysis integrates primary and secondary evidence streams with rigorous validation to ensure credibility and relevance. Primary inputs included in-depth interviews with practicing surgeons, hospital administrators, supply chain leaders, and senior clinicians across referral centers, veterinary hospitals and clinics, augmented by structured surveys to capture operational priorities and adoption barriers. Secondary research synthesized peer-reviewed clinical literature, regulatory guidance, device registries and technical specifications to map technological trajectories and safety considerations.

Data were triangulated through comparative analysis across animal types, procedure categories and techniques, and regional patterns were cross-validated with institutional case mix data and procurement records where available. Qualitative insights were coded to identify recurring themes in training, interoperability and post-market support. Throughout the methodology, care was taken to anonymize respondent data, to document source provenance, and to subject findings to internal expert review, ensuring that the conclusions reflect both practical experience and empirical evidence rather than anecdote alone.

Concise synthesis emphasizing the intersection of clinical innovation, operational strategy and regional nuance as determinants of future leadership in veterinary surgery

In conclusion, the veterinary surgical domain is at an inflection point where technological capability, clinical specialization and commercial strategy intersect to shape future standards of care. The confluence of minimally invasive techniques, enhanced imaging, and nascent robotic applications is expanding the envelope of treatable conditions, while segmentation by animal type, procedure, technique and end-user exposes clear pathways for targeted innovation and adoption. Regional differences in infrastructure, regulation and investment appetite require nuanced strategies that reflect local realities without forgoing global best practices.

Leaders who integrate supply chain resilience, clinician education and data-driven outcome measurement into their strategic plans will be best positioned to translate capability into consistent, high-value care. The recommendations and insights presented here provide a foundation for operationalizing those priorities and for making informed choices about product development, partnership models and market entry approaches. As clinical expectations rise, the ability to align clinical effectiveness with sustainable business models will determine which organizations lead the next wave of specialty veterinary care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Surgical Procedures Market, by Animal Type

  • 8.1. Companion Animal
    • 8.1.1. Cats
    • 8.1.2. Dogs
  • 8.2. Equine Animal
  • 8.3. Livestock Poultry
    • 8.3.1. Livestock
    • 8.3.2. Poultry

9. Veterinary Surgical Procedures Market, by Procedure Type

  • 9.1. Dental
  • 9.2. Neurological
  • 9.3. Ophthalmic
  • 9.4. Orthopedic
  • 9.5. Soft Tissue

10. Veterinary Surgical Procedures Market, by Technique

  • 10.1. Minimally Invasive
    • 10.1.1. Arthroscopic
    • 10.1.2. Laparoscopic
  • 10.2. Open
  • 10.3. Robotic

11. Veterinary Surgical Procedures Market, by End User

  • 11.1. Referral Centers
  • 11.2. Veterinary Clinics
  • 11.3. Veterinary Hospitals

12. Veterinary Surgical Procedures Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Veterinary Surgical Procedures Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Veterinary Surgical Procedures Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Veterinary Surgical Procedures Market

16. China Veterinary Surgical Procedures Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. B. Braun Melsungen AG
  • 17.6. Becton, Dickinson and Company
  • 17.7. Covetrus, Inc.
  • 17.8. Henry Schein, Inc.
  • 17.9. Heska Corporation
  • 17.10. Jorgen Kruuse A/S
  • 17.11. Medtronic plc
  • 17.12. Midmark Corp.
  • 17.13. Patterson Companies, Inc.
  • 17.14. Smith & Nephew plc
  • 17.15. Stryker Corporation
  • 17.16. Vetoquinol S.A.
  • 17.17. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES VETERINARY SURGICAL PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA VETERINARY SURGICAL PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY CATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY CATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY CATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY DOGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY DOGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY EQUINE ANIMAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY EQUINE ANIMAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY EQUINE ANIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY NEUROLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY NEUROLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY OPHTHALMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY OPHTHALMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY OPHTHALMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY SOFT TISSUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY SOFT TISSUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY SOFT TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ARTHROSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ARTHROSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ARTHROSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY OPEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY OPEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ROBOTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ROBOTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ROBOTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY REFERRAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY REFERRAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY REFERRAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GCC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GCC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. GCC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 146. GCC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GCC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. GCC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 149. GCC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 150. GCC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. G7 VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. G7 VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. G7 VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 170. G7 VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
  • TABLE 171. G7 VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. G7 VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 173. G7 VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 174. G7 VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. NATO VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. NATO VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. NATO VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 178. NATO VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
  • TABLE 179. NATO VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. NATO VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 181. NATO VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 182. NATO VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES VETERINARY SURGICAL PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA VETERINARY SURGICAL PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)